Publicaciones (39) Publicaciones de María Inmaculada Dominguez Mozo

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  2. MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate

    Biomedicines, Vol. 11, Núm. 10

  3. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

2022

  1. Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Biomedicines, Vol. 10, Núm. 2

  2. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study

    Frontiers in Immunology, Vol. 13

  3. Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients

    Biology, Vol. 11, Núm. 11

  4. Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study

    European Journal of Neurology, Vol. 29, Núm. 3, pp. 895-900

  5. microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate

    Frontiers in Immunology, Vol. 13

2021

  1. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Frontiers in Immunology, Vol. 12

  2. Evolution of antibody titres against Epstein–Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients

    Scientific Reports, Vol. 11, Núm. 1

  3. Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

    Cells, Vol. 10, Núm. 1

  4. Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

    Frontiers in Immunology, Vol. 12

2020

  1. A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis

    Frontiers in Immunology, Vol. 11

  2. Acetate correlates with disability and immune response in multiple sclerosis

    PeerJ, Vol. 8

  3. MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients

    Frontiers in Immunology, Vol. 11

  4. Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

    Scientific Reports, Vol. 10, Núm. 1

  5. Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients

    European Journal of Immunology, Vol. 50, Núm. 5, pp. 685-694

2019

  1. Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain

    PeerJ, Vol. 2019, Núm. 12

  2. Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study

    European Journal of Neurology, Vol. 26, Núm. 9, pp. 1200-1204

2018

  1. Blood lymphocyte subsets identify optimal responders to IFN-beta in MS

    Journal of Neurology, Vol. 265, Núm. 1, pp. 24-31